Clinical Trials Browser

Phase 1/2 × Recurrence × gilteritinib × Clear all

NCT04988555 2025-04-02

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05279859 2022-06-15

HERKULES-4

Phase 1/2 Withdrawn

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute